AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 31 filers reported holding AGEX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50 | -24.2% | 74 | 0.0% | 0.00% | – |
| Q2 2023 | $66 | +34.7% | 74 | 0.0% | 0.00% | – |
| Q1 2023 | $49 | -73.4% | 74 | -77.8% | 0.00% | – |
| Q4 2022 | $184 | -99.9% | 334 | 0.0% | 0.00% | – |
| Q3 2022 | $188,000 | -2.1% | 334 | 0.0% | 0.00% | – |
| Q2 2022 | $192,000 | -64.5% | 334 | -47.3% | 0.00% | – |
| Q1 2022 | $541,000 | -21.7% | 634 | 0.0% | 0.00% | – |
| Q4 2021 | $691,000 | +15.9% | 634 | 0.0% | 0.00% | – |
| Q3 2021 | $596,000 | -39.4% | 634 | 0.0% | 0.00% | – |
| Q2 2021 | $983,000 | -4.3% | 634 | 0.0% | 0.00% | – |
| Q1 2021 | $1,027,000 | +6.5% | 634 | 0.0% | 0.00% | – |
| Q4 2020 | $964,000 | -73.6% | 634 | -85.9% | 0.00% | – |
| Q3 2020 | $3,649,000 | -47.9% | 4,505 | -39.1% | 0.00% | – |
| Q2 2020 | $7,002,000 | -9.7% | 7,396 | -11.3% | 0.00% | – |
| Q1 2020 | $7,752,000 | +47.2% | 8,336 | +188.1% | 0.00% | – |
| Q4 2019 | $5,265,000 | +21.2% | 2,893 | +30.6% | 0.00% | – |
| Q3 2019 | $4,343,000 | -2.3% | 2,216 | +83.0% | 0.00% | – |
| Q2 2019 | $4,444,000 | – | 1,211 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 2,997,156 | $2,038,066 | 0.18% |
| Beirne Wealth Consulting Services, LLC | 18,000 | $16,077 | 0.01% |
| Strategic Wealth Investment Group, LLC | 92,603 | $62,970 | 0.01% |
| Prescott General Partners LLC | 185,185 | $125,926 | 0.01% |
| Summit X, LLC | 37,000 | $25,160 | 0.01% |
| Sigma Planning Corp | 181,385 | $123,342 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 144,770 | $98,444 | 0.00% |
| Piscataqua Savings Bank | 1,000 | $680 | 0.00% |
| UBS Group AG | 235 | $160 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 74 | $50 | 0.00% |